ClinicalTrials.gov
ClinicalTrials.gov Menu

Prospective Data Collection of Patients With Diffuse Parenchymal Lung Diseases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01600378
Recruitment Status : Recruiting
First Posted : May 17, 2012
Last Update Posted : November 8, 2017
Sponsor:
Information provided by (Responsible Party):
Singapore General Hospital

Brief Summary:
The purpose of this study is to generate a prospective database of all patients evaluated for diffuse parenchymal lung diseases to provide much needed data on the various disease aetiologies, incidence and prevalence rates, clinical and radiological presentations, pathologic correlations, disease progression and response to treatment, and final outcomes in this group of patients in Singapore.

Condition or disease
Diffuse Parenchymal Lung Diseases

Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Prospective Data Collection of Clinical, Pulmonary Function, Radiological, Bronchoscopic and Fibered Confocal Fluorescence Microscopy Imaging, and Pathological Characteristics in Patients With Diffuse Parenchymal Lung Diseases
Study Start Date : May 2012
Estimated Primary Completion Date : April 2022
Estimated Study Completion Date : April 2022





Primary Outcome Measures :
  1. Final diagnoses of patients presenting with diffuse parenchymal lung disease after complete evaluation [ Time Frame: 3 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients evaluated for diffuse parenchymal lung diseases
Criteria

Inclusion Criteria:

  • All patients 21 years old and older diagnosed with suspected diffuse parenchymal lung disease (multi-lobar pulmonary infiltrates)

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01600378


Contacts
Contact: Su Ying Low, BMBCh +65 63214700 low.su.ying@sgh.com.sg

Locations
Singapore
Singapore General Hospital Recruiting
Singapore, Singapore, 169608
Contact: Su Ying Low, BMBCh    +65 3214700    low.su.ying@sgh.com.sg   
Principal Investigator: Su Ying Low, BMBCh         
Sponsors and Collaborators
Singapore General Hospital
Investigators
Principal Investigator: Su Ying Low, BMBCh Singapore General Hospital

Publications:
Responsible Party: Singapore General Hospital
ClinicalTrials.gov Identifier: NCT01600378     History of Changes
Other Study ID Numbers: 2012/245/Cilddatabase
First Posted: May 17, 2012    Key Record Dates
Last Update Posted: November 8, 2017
Last Verified: November 2017

Keywords provided by Singapore General Hospital:
diffuse parenchymal lung disease
interstitial lung disease
idiopathic pulmonary fibrosis

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Interstitial
Respiratory Tract Diseases